SCHEMBL7541257

SCHEMBL7541257

O=C(O)C(=O)Nc1nc2ccccc2cc1C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.62
PTPRC P08575 2/20 0.44
PTPN2 P17706 2/20 0.44
PTPRB P23467 2/20 0.44
PTPRE P23469 2/20 0.44
PTPN6 P29350 2/20 0.44
IKBKB O14920 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MEN1 O00255 2/20 0.43
ALDH1A1 P00352 2/20 0.43
KMT2A Q03164 2/20 0.43
TP53 P04637 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.43
SORT1 Q99523 1/20 0.42
MGAM O43451 2/20 0.41
IDO1 P14902 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7536305 0.78 PTPN1 (0.50) PTPN1PTPRCPTPN2PTPRBPTPRE
SCHEMBL27492651 0.77 KDM4E (0.56) SMN1; SMN2NPC1RAB9AALDH1A1TP53
SCHEMBL4311266 0.77 PTPN1 (1.00) PTPN1PTPRCPTPN2PTPRBPTPRE
SCHEMBL23629067 0.76 POLB (0.44) PTPN1IKBKBNPC1RAB9AKMT2A
SCHEMBL7534640 0.75 PTPN1 (0.62) PTPN1PTPRCPTPN2PTPRBPTPRE
SCHEMBL27533255 0.74 CASP3 (0.54) SMN1; SMN2NPC1RAB9AMEN1ALDH1A1
SCHEMBL8807038 0.74 SMN1; SMN2 (0.56) PTPN1IKBKBSMN1; SMN2NPC1RAB9A
SCHEMBL17241734 0.74 SYK (0.47) SMN1; SMN2RAB9AMEN1ALDH1A1KMT2A
SCHEMBL70017 0.73 ALDH1A1 (0.61) PTPN1IKBKBSMN1; SMN2NPC1RAB9A
SCHEMBL31133499 0.73 IKBKB (0.51) PTPN1IKBKBSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020019412-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2002-02-14 US claimed
US-20020019412-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2002-02-14 US disclosed
EP-1062218-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) NOVO NORDISK A/S (DK) 2000-12-27 EP disclosed
WO-1999046268-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) NOVO NORDISK A/S (DK) 1999-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019412-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) PTPRCAP, PTPRS, PTPRA PTPN1 7/4885PTPRC 6/4885PTPN2 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.